Immunogen Inc. buy JPMorgan Chase & Co.
Start price
13.09.23
/
50%
€15.24
Target price
13.09.24
€20.50
Performance (%)
90.15%
End price
14.09.24
-
Summary
This prediction is currently being closed. The BUY prediction by JPMorgan_Chase___Co_ for Immunogen Inc. has seen massive gains of 90.15%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Immunogen Inc. | - | - | - |
| iShares Core DAX® | 0.224% | 2.031% | 21.399% |
| iShares Nasdaq 100 | 0.371% | -0.955% | 5.637% |
| iShares Nikkei 225® | 0.972% | -0.953% | 13.432% |
| iShares S&P 500 | 0.417% | -0.622% | 3.310% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Immunogen Inc. diskutieren
ImmunoGen, Inc. (NASDAQ: IMGN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $22.00 price target on the stock, up previously from $9.00.
Ratings data for IMGN provided by MarketBeat
In the thread Trading Immunogen Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten